Abstract:Objective The incidence of acute pulmonary injury occurred after cardiopulmonary bypass for fallot tetrad has been high. The severity of pulmonary ischemia-reperfusion has been found to be reduced with ulinastatin (UTI) in the animal models and clinical practice. We evaluated the effect of pulmonary artery perfusion with a hypothermic protective solution containing ulinastatin on the inflammatory response in the lung during cardiopulmonary bypass. Methods 30 children with tetralogy of Fallot (TOF) were randomly assigned into control group and protective group, 15 cases in each group. Patients would be excluded if they had signs of infections, such as the white blood cell count was over 12000 per microliter, the temperature was above 38 centi-degree and the c-reaction protein was more than 8 mg/L. Operation with routine approaches was performed in the control group and the pulmonary artery was infused with 4℃ protective solution in the protective group while the heart stoped beating. Plasma tumor necrosis factor α (TNF-α) 、CD11b and Myeloperoxidase (MPO) were measured intraoperatively and postoperatively. Blood gas、pulmonary function and clinic index of the patients were also monitored. Results The level of TNF-α was lower in the protective group as compared with that in the control group immediately and 3 hours after closing the sternum [(11.15±2.47) pg/ml vs. (14.21 ±5.55) pg/ml, P<0.05; (12.01 ±2.69) pg/ml vs. (15.94 ±4.86)pg/ml,P <0.01]. The MFI of CD11b was lower in the protective group as compared with that in the control group at 3 and 6 hoursafter closing the sternum (126.23±36.05 vs. 156.98±48.34, P<0.05; 137.27±38.85 vs. 173.27±67.43, P<0.05). The level of MPO was lower in protective group as compared with that in the control group at 3 hours, 6 hours and 24hours after closing the sternum [(156.52±17.57)U/L vs.(178.45±35.68)U/L, P<0.05; (178.28±23.63) U/L vs.(224.66±49.66)U/L, P<0.01;(130.52±57.50)U/L vs. (96.50±14.49)U/L, P<0.05]. The duration of mechanical ventilation was significantly shorter in the protective group than that in the control group (17.60±6.39 vs. 23.70±8.51,P<0.05). Alveolar-arterial oxygen pressure difference (A-aDO2, calculated as [FiO2×713-5/4×PaCO2]-PaO2) in the protective group was less than that in the control group at 3 and 6 hours after closing the sternum [(120.92±33.08)mm Hg vs. (145.52±39.38)mmHg, P<0.05;(74.76±40.16)mm Hg vs. (112.50±44.16)mmHg, P<0.01]. Dynamic compliance (Cdyn) in protective group was lower than that in control group at 3 and 6 hours after closing the sternum [(0.59±0.11)ml·cmH2O-1·kg-1 vs. (0.46±0.17)ml·cmH2O-1·kg-1, P<0.05;(0.67±0.09)ml·cmH2O-1·kg-1vs. (0.53±0.18)ml·cmH2O-1·kg-1,P<0.05). Conclusion Perfusion with hypothermic protective solution containing UTI to the pulmonary artery during cardiopulmonary bypass may reduce the inflammatory responses substantially in the lung after bypass and had a role in the lung protection.

Protective effect of doxycycline on myocardial ischemia-reperfusion injury after cardiopulmonary bypass

The Protective Effect of Aminophylline on Myocardium During Cardiopulmonary Bypass

Doxorubicin induced rabbit myocardium injury and protective effect of murine on myocardium

Clinical Study of the Protective Effect of Exogenous Creatine Phosphate on Ischemic Myocardium During Open Heart Surgery

The protective role of hypothermic protective solution during surgey for the tetralogy of Fallot

Effects of doxycycline on the distribution of gap junction and susceptibility of arrhythmias in isolated ischemia-reperfusion rat hearts

In Vivo Study on Doxycycline Protective Mechanisms during Myocardial Ischemia Injury in Rats

The myocardial protective effects of L-carnitine under open cardiac operation

Protective effect of hyperoxia liquid preconditioning on myocardium during coronary artery bypass graft

Protective effect of penehyclidine hydrochloride on post-CPB lung injury

[Effects of Ischemic Reperfusion on the Expression of Cell Adhesion Molecules and Monocyte Chemotactic Protein-1 and the Protective Role of MgSO4].

Low Dose Cyclophosphamide Rescues Myocardial Function from Ischemia-Reperfusion in Rats

Effects of Dexamethasone on Toll-Like Receptor(tlr)2 and 4 in CD14+ Monocyte of Patients During and after Cardiac Surgery with Cardiopulmonary Bypass

The effect of cardiopulmonary bypass on the activation of peripheral T lymphocytes in children under open - heart operation

Influence of beating and arrested heart surgery with cardiopulmonary bypass on prostaglandins

Protective effects of Ulinastatin on lung injury in pediatric patients undergoing cardiopulmonary bypass

The effect of cardiopulmonary bypass on monocyte HLA-DR expression

ASSA13-03-53 Effects of Doxycycline on Cx43 Distribution and Cardiac Arrhythmia Susceptibility of Rats after Myocardial Infarction

Up-regulation of MMP-2 and MMP-9 Leads to Degradation of Type IV Collagen During Skeletal Muscle Reperfusion Injury; Protection by the MMP Inhibitor, Doxycycline

Myocardial protective effect of nicorandil premedication In patients undergoing coronary artery bypass grafting with cardiopulmonary bypass

The Study of Effects of Custodiol HTK Solution on Myocardial Protection in Cardiac Operation